Singh Kritarth Naman M, Shetty Yashashri C
Department of Pharmacology and Therapeutics, Seth G.S. Medical College and K.E.M. Hospital, Mumbai, Maharashtra, India.
Perspect Clin Res. 2017 Apr-Jun;8(2):63-67. doi: 10.4103/2229-3485.203036.
Clinical trials and research studies are being conducted worldwide at a rampant pace leading to generation of large amount of data. However, to reap the benefits of the data generated it is important that this data is shared with the general public without which it can be deemed useless. Despite its importance being known to us, data sharing does not come without its share of problems and it is not as easy to execute as it sounds on-paper. Over the past few years, multiple coveted organizations around the world involved in research activities have come up with their respective guidelines and initiatives to make sure the sharing of research data is smooth and ethical. Developing countries like India have made a few strides in the right direction with some initiatives in-place, but there still seems a long way to go before unanimous data sharing can be a reality. The stakeholders may have to face certain possible repercussions due to data sharing but there is no doubt that if done in the right way, it can lead to universal development.
全球范围内，临床试验和研究正在迅猛开展，产生了大量数据。然而，要从所产生的数据中获益，重要的是将这些数据与公众共享，否则数据可能被视为无用。尽管我们知道数据共享很重要，但它并非没有问题，而且执行起来并不像书面听起来那么容易。在过去几年里，世界各地多个参与研究活动的令人垂涎的组织已经出台了各自的指导方针和举措，以确保研究数据的共享顺利且合乎道德。像印度这样的发展中国家已经通过一些已实施的举措在正确的方向上取得了一些进展，但在实现一致的数据共享成为现实之前，似乎仍有很长的路要走。利益相关者可能会因数据共享而面临某些可能的影响，但毫无疑问，如果以正确的方式进行，它可以带来普遍发展。
